Clinical Trial Update: Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the efficacy, pharmacokinetics, and safety of two subcutaneous injections of a six-month triptorelin embonate formulation in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Triptorelin Embonate 6 Month Formulation (triptorelin embonate)

Snippet

Sponsor: Debiopharm International SA | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-09-15